Cartesian Growth Corporation II
$12.71$0.00 (0.0%)
Cartesian Growth Corporation II’s quoted price sits in the upper half of its reported 52-week range, 4.94% below the high.
NYSE · BFAC · USD
Stock price, earnings
Quote as of Dec 13, 2024, 04:31 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Battery Future Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 3.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Battery Future Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Battery Future Acquisition Corp. (BFAC) is a special purpose acquisition company with no substantive ongoing operations. Its primary objective is to engage in a strategic business combination, such as a merger, asset acquisition, share purchase, or reorganization, with one or more existing enterprises. The company's focus for this acquisition is on industries at the forefront of the global shift from fossil fuels towards electrification, specifically targeting businesses across the entire battery value chain. Established in 2021, the firm maintains its corporate base in Miami, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:08 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$12.71$0.00 (0.0%)
Cartesian Growth Corporation II’s quoted price sits in the upper half of its reported 52-week range, 4.94% below the high.
$11.00+$0.01 (+0.09%)
Enphys Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.36% below the high.
$11.39-$0.18 (-1.56%)
Mountain & Co. I Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.7% below the high.
$10.75-$0.03 (-0.23%)
HH&L Acquisition Co.’s quoted price sits in the lower half of its reported 52-week range, 4.87% below the high.
$11.08-$0.04 (-0.36%)
Ross Acquisition Corp II’s quoted price sits in the upper half of its reported 52-week range, 0.36% below the high.
$10.43$0.00 (0.0%)
LAVA Medtech Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 3.87% below the high.
$11.58$0.00 (0.0%)
Blockchain Coinvestors Acquisition Corp. I: Financial Services · Shell Companies.
$10.54+$0.01 (+0.1%)
Landcadia Holdings IV, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.19% below the high.